Glioblastoma remains the most common form of brain cancer, exhibiting enormous heterogeneity in the tumor and immune compartments within both the same tumor and between patients. To characterize this heterogeneity within tumor samples and in vitro models, we utilized the Parse Evercode V2 assay to profile whole cells processed from a patient-derived neurosphere line alongside nuclei isolated from a piece of flash-frozen glioblastoma tissue.
This session is part of Parse Biosciences’ 2023 Brain Awareness Month.